Merrion Pharma to raise funds to develop products
Company has already raised $24m and now hopes to develop drug delivery technology through flotation, writes Gavin Daly.
Company has already raised $24m and now hopes to develop drug delivery technology through flotation, writes Gavin Daly.
Merrion Pharmaceuticals, the Dublin Firm that plans to list in Ireland and the US next month, is betting on investor interest in the potential of its drugs.
The company has a limited trading history, with turnover of just over $200,000 (€150,000) from the time it was founded in December 2003 to the end of September last year.
Subscribe from just €1 for the first month!
What's Included
With any subscription you will have access to
-
Unlimited multi-device access to our iPad, iPhone and Android Apps
-
Unlimited access to our eReader library
-
Exclusive daily insight and opinion seven days a week
-
Create alerts to never miss a subject that matters to you
-
Get access to exclusive offers for subscribers on gifts and experiences
-
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine
Related Stories
The year in review
The best writing and and the biggest stories of 2019 from the Business Post
Newsround: What Thursday’s papers say
Denis O’Brien is back in court, residents continue to fight the Council on halting site and a row surfaces in government over rent control proposals
More cycle routes, expansion of Luas to Bray and new bus network proposed
Greater Dublin Area draft Transport Strategy published
